Capitalmind
Capitalmind
Actionable insights on equities, fixed-income, macros and personal finance Start 14-Days Free Trial
Actionable investing insights Get Free Trial

85 ArticlesPharmaceuticals

1 / 9

Solara Active Pharma Sciences – From David to Goliath

This is a guest post by Saket Mehrotra. Number cruncher, avid reader, coffee connoisseur, book store hopper & Metallica fan. An active follower of Sensex ...
SAPS.jpg

Outlier in Focus – Divi’s Laboratories.

We come across a large number of interesting stocks in Capitalmind SNAP Outliers, our discovery tool for stocks with momentum. Here’s a look at Divi's ...
Outlier-in-Focus.png

Dr Reddy’s USFDA Inspection of Oncology Formulation Manufacturing Facility at Duvvada – Form 483 Revealed

Today we cover the Form 483 issued by the US FDA to Dr. Reddy’s oncology formulation ...
Dr-Reddy-Duvvada-1.png

Cadila Healthcare US FDA Inspection of Baddi – Form 483 Revealed

Today we cover the Form 483 issued by the US FDA to Cadila Healthcare’s formulations manufacturing plant at Baddi. ...
Cadila-483.png

Dr Reddy’s Laboratories US FDA Inspection of Miryalaguda – Form 483 Revealed

Today we cover the Form 483 issued by the US FDA to Dr. Reddy’s API manufacturing plant at Miryalaguda. ...
Dr-Reddy-Miryalguda-2.png

We Reveal The Observations Made By US FDA’s Inspection Of Natco’s Kothur Facility

True to our promise of keeping a tab on the regulatory inspections of Indian Pharmaceutical companies, we are happy to get our hands on the Form 483 issued ...
Natco-Kothur-483.png

Exclusive: We Reveal The Observations Made By US FDA’s Inspection Of Granules OmniChem's Vizag Facility

True to our promise of keeping a tab on the regulatory inspections of Indian Pharmaceutical companies, we are happy to get our hands on the Form 483 issued ...
Granules-OmniChem.jpg

“They’re getting away with murder” – How Big A Bite Will Trump Take?

How do you make a first impression? Something like what the American President-elect Donald Trump did in his first press conference since being elected the ...
Trump-Comments-Pharma.png

We Reveal The Form 483 Issued By US FDAs Inspection Of Divis Laboratories Unit-II At Visakhapatnam

Here is our coverage of the Form 483 issued by the US FDA from the inspection of Divis Laboratories Unit-II located at Visakhapatnam. You can catch all our ...
Divis-Laboratories-FDA-Inspection.png

Exclusive: We Reveal The Observations Made By US FDA’s Inspection Of Sun Pharma’s Halol Facility

True to our promise of keeping a tab on the US FDAs inspection of Sun Pharma’s Halol facility, we are happy to get our hands on the Form 483 issued for ...
US-FDA-Sun-Pharma-Halol-Form-483-2.png